Jun 28, 2022
Ipsen to Buy Biopharmaceutical Company Epizyme for USD 247 Million The restructuring of French manufacturer Ipsen has progressed with a takeover agreement for US competitor Epizyme and its cancer drug Tazverik in a deal for slightly less than USD 250 million. Ipsen is proposing USD 1.45 per share for Epizyme, va...
Read More...
Jun 27, 2022
In the current scenario, with an unabating urge to maintain good mental health, individuals seem quite aware of sanity and are much more likely to talk about it openly. More people are accessing care, which in turn, accounts for a notable rise in the number of cases. However, what is really steering this increase s...
Read More...
Mar 02, 2025
In the contemporary world, major depressive disorder (MDD) is one of the diseases responsible for the greatest healthcare burden. In the United States, more than 24 million people suffer from major depressive disorder each year, while in Europe, about 20 million are diagnosed with the major depressive disorder each...
Read More...
Jun 23, 2022
Conformal Medical Announces Launch of CONFORM Pivotal Trial On June 17, 2022, Conformal Medical Inc, is a medical device company manufacturing devices to avoid strokes in patients with non-valvular atrial fibrillation and developing next-generation LAAO technology. Its exclusive technology is intended to make le...
Read More...
Nov 04, 2025
In the annals of medical progress, few fields hold as much transformative potential as nanomedicine. Operating at the scale of a billionth of a meter, this revolutionary discipline is fundamentally changing the way we diagnose, treat, and prevent diseases. Far from being a theoretical concept, nanomedicine in healt...
Read More...
Jun 21, 2022
Biogen terminates USD 217 Million ALS Pact with Karyopharm Biogen has backed out of the four-year-old partnership with Karyopharm on a drug candidate for the neurological disease amyotrophic lateral sclerosis, which could have cost the US biotech up to USD 217 million. The 2018 agreement that granted Biogen righ...
Read More...
Jun 20, 2022
The rising cost of medication development has put pressure on R&D organizations to contribute to greater efficiency in developing novel drugs. In recent years, the pharmaceutical industry has made tremendous efforts to solve these issues and improve the efficiency of the drug development process. Indubitably, s...
Read More...
Jul 11, 2022
Warts are small, benign fleshy growths of the skin or mucous membranes caused by various strains of the human papillomavirus (HPV). Genital Warts (condyloma acuminatum) are the clinical manifestations of a sexually transmitted infection caused by HPV. HPV is the most common sexually transmitted infection ...
Read More...
Jun 17, 2022
Obesity is a chronic health condition that leads to abnormal or excessive fat accumulation or adipose tissue in the body that presents a health risk. It is an imbalance between calories ingested and calories burned. The factors responsible for the causes of obesity include heredity, a sedentary lifestyle, excessive...
Read More...
Jun 16, 2022
US FDA Grants 510K Clearance for Aurora Spine’s Interbody Fusion Device On June 07, 2022, Aurora Spine, Inc. a designer and manufacturer of innovative medical devices, is an emerging growth company focused on delivering new solutions to the spinal implant and pain management industries through a series of screwl...
Read More...